116 related articles for article (PubMed ID: 3574772)
1. Chronic imipramine treatment reduces (+)2-[125I]iodolysergic acid, diethylamide but not 125I-neuropeptide Y binding in layer IV of rat cerebral cortex.
Cummins JT; von Euler G; Fuxe K; Ogren SO; Agnati LF
Neurosci Lett; 1987 Mar; 75(2):152-6. PubMed ID: 3574772
[TBL] [Abstract][Full Text] [Related]
2. Localization and characterization by quantitative autoradiography of [125I]LSD binding sites in rat brain.
Nakada MT; Wieczorek CM; Rainbow TC
Neurosci Lett; 1984 Aug; 49(1-2):13-8. PubMed ID: 6493586
[TBL] [Abstract][Full Text] [Related]
3. Characterization of 125I-lysergic acid diethylamide binding to serotonin receptors in rat frontal cortex.
Kadan MJ; Krohn AM; Evans MJ; Waltz RL; Hartig PR
J Neurochem; 1984 Sep; 43(3):601-6. PubMed ID: 6747625
[TBL] [Abstract][Full Text] [Related]
4. Chronic effects of imipramine and lithium on 5-HT receptor subtypes in rat frontal cortex, hippocampus and choroid plexus: quantitative receptor autoradiographic analysis.
Mizuta T; Segawa T
Jpn J Pharmacol; 1989 Jul; 50(3):315-26. PubMed ID: 2761132
[TBL] [Abstract][Full Text] [Related]
5. Lysergic acid diethylamide (LSD) administration selectively downregulates serotonin2 receptors in rat brain.
Buckholtz NS; Zhou DF; Freedman DX; Potter WZ
Neuropsychopharmacology; 1990 Apr; 3(2):137-48. PubMed ID: 1969270
[TBL] [Abstract][Full Text] [Related]
6. N1-methyl-2-125I-lysergic acid diethylamide, a preferred ligand for in vitro and in vivo characterization of serotonin receptors.
Hoffman BJ; Scheffel U; Lever JR; Karpa MD; Hartig PR
J Neurochem; 1987 Jan; 48(1):115-24. PubMed ID: 3794694
[TBL] [Abstract][Full Text] [Related]
7. Repeated administration of MDMA causes transient down-regulation of serotonin 5-HT2 receptors.
Scheffel U; Lever JR; Stathis M; Ricaurte GA
Neuropharmacology; 1992 Sep; 31(9):881-93. PubMed ID: 1359444
[TBL] [Abstract][Full Text] [Related]
8. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex.
Gresch PJ; Smith RL; Barrett RJ; Sanders-Bush E
Neuropsychopharmacology; 2005 Sep; 30(9):1693-702. PubMed ID: 15756304
[TBL] [Abstract][Full Text] [Related]
9. Radioiodinated D-(+)-N1-ethyl-2-iodolysergic acid diethylamide: a ligand for in vitro and in vivo studies of serotonin receptors.
Lever JR; Scheffel UA; Musachio JL; Stathis M; Wagner HN
Life Sci; 1991; 48(15):PL73-8. PubMed ID: 2011045
[TBL] [Abstract][Full Text] [Related]
10. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.
Appel NM; Mitchell WM; Garlick RK; Glennon RA; Teitler M; De Souza EB
J Pharmacol Exp Ther; 1990 Nov; 255(2):843-57. PubMed ID: 2243353
[TBL] [Abstract][Full Text] [Related]
11. Correspondence between 5-HT2 receptors and serotonergic axons in rat neocortex.
Blue ME; Yagaloff KA; Mamounas LA; Hartig PR; Molliver ME
Brain Res; 1988 Jun; 453(1-2):315-28. PubMed ID: 3401769
[TBL] [Abstract][Full Text] [Related]
12. Quantitative receptor autoradiography: application to the study of multiple serotonin receptors in rat cortex.
Palacios JM
Adv Biochem Psychopharmacol; 1983; 37():455-63. PubMed ID: 6637602
[No Abstract] [Full Text] [Related]
13. 5HT2 receptor changes in rat cortex and platelets following chronic ritanserin and clorgyline administration.
Twist EC; Mitchell S; Brazell C; Stahl SM; Campbell IC
Biochem Pharmacol; 1990 Jan; 39(1):161-6. PubMed ID: 1688704
[TBL] [Abstract][Full Text] [Related]
14. d-LSD binding to brain homogenates: possible relationship to serotonin receptors.
Bennett JL; Aghajanian GK
Life Sci; 1974 Dec; 15(11):1935-44. PubMed ID: 4620998
[No Abstract] [Full Text] [Related]
15. The effect of chronic imipramine administration on the densities of 5-HT1A and 5-HT2 receptors and the abundances of 5-HT receptor and transporter mRNA in the cortex, hippocampus and dorsal raphe of three strains of rat.
Burnet PW; Michelson D; Smith MA; Gold PW; Sternberg EM
Brain Res; 1994 Feb; 638(1-2):311-24. PubMed ID: 8199869
[TBL] [Abstract][Full Text] [Related]
16. In vivo binding of 125I-LSD to serotonin 5-HT2 receptors in mouse brain.
Hartig PR; Scheffel U; Frost JJ; Wagner HN
Life Sci; 1985 Aug; 37(7):657-64. PubMed ID: 3160905
[TBL] [Abstract][Full Text] [Related]
17. Effects of imipramine and serotonin-2 agonists and antagonists on serotonin-2 and beta-adrenergic receptors following noradrenergic or serotonergic denervation.
Eison AS; Eison MS; Yocca FD; Gianutsos G
Life Sci; 1989; 44(19):1419-27. PubMed ID: 2785627
[TBL] [Abstract][Full Text] [Related]
18. Stress and antidepressant effects on hippocampal and cortical 5-HT1A and 5-HT2 receptors and transport sites for serotonin.
Watanabe Y; Sakai RR; McEwen BS; Mendelson S
Brain Res; 1993 Jun; 615(1):87-94. PubMed ID: 8364729
[TBL] [Abstract][Full Text] [Related]
19. Autoradiographic localization and characterization of [125I]lysergic acid diethylamide binding to serotonin receptors in Aplysia.
Kadan MJ; Hartig PR
Neuroscience; 1988 Mar; 24(3):1089-102. PubMed ID: 3380298
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of serotonin (5-HT) lesions and synthesis blockade on neuropeptide-Y immunoreactivity and 5-HT1A, 5-HT1B/1D and 5-HT2A/2C receptor binding sites in the rat cerebral cortex.
Compan V; Segu L; Buhot MC; Daszuta A
Brain Res; 1998 Jun; 795(1-2):264-76. PubMed ID: 9622647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
